Ionis Pharmaceuticals Inc
NASDAQ:IONS

Watchlist Manager
Ionis Pharmaceuticals Inc Logo
Ionis Pharmaceuticals Inc
NASDAQ:IONS
Watchlist
Price: 79.46 USD 1.06%
Market Cap: 12.9B USD

Wall Street
Price Targets

IONS Price Targets Summary
Ionis Pharmaceuticals Inc

Wall Street analysts forecast IONS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IONS is 85.6 USD with a low forecast of 46.46 USD and a high forecast of 115.5 USD.

Lowest
Price Target
46.46 USD
42% Downside
Average
Price Target
85.6 USD
8% Upside
Highest
Price Target
115.5 USD
45% Upside
Ionis Pharmaceuticals Inc Competitors:
Price Targets
PHARM
Pharming Group NV
37% Upside
ADMA
ADMA Biologics Inc
38% Upside
BSLN
Basilea Pharmaceutica AG
54% Upside
688105
Nanjing Vazyme Biotech Co Ltd
40% Upside
COYA
Coya Therapeutics Inc
169% Upside
300896
Imeik Technology Development Co Ltd
43% Upside
MDGL
Madrigal Pharmaceuticals Inc
3% Upside
PASG
Passage Bio Inc
288% Upside

Revenue
Forecast

Revenue Estimate
Ionis Pharmaceuticals Inc

For the last 13 years the compound annual growth rate for Ionis Pharmaceuticals Inc's revenue is 16%. The projected CAGR for the next 3 years is 25%.

16%
Past Growth
25%
Estimated Growth
Estimates Accuracy
5%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Ionis Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Ionis Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-34%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IONS's stock price target?
Price Target
85.6 USD

According to Wall Street analysts, the average 1-year price target for IONS is 85.6 USD with a low forecast of 46.46 USD and a high forecast of 115.5 USD.

What is Ionis Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
25%

For the last 13 years the compound annual growth rate for Ionis Pharmaceuticals Inc's revenue is 16%. The projected CAGR for the next 3 years is 25%.

Back to Top